As of 2025-07-01, the Intrinsic Value of Pharmadrug Inc (PHRX.CN) is -0.03 CAD. This PHRX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Pharmadrug Inc is -283.12%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Pharmadrug Inc (PHRX.CN) is overvalued by 283.12%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.03 - -0.03 | -0.03 | -283.12% |
| DDM - Stable | (0.04) - (0.08) | (0.06) | -501.1% |
| DDM - Multi | (1.04) - (1.86) | (1.34) | -9028.0% |
| Market Cap (mil) | 1.08 |
| Beta | 1.78 |
| Outstanding shares (mil) | 72.16 |
| Enterprise Value (mil) | 2.39 |
| Market risk premium | 5.10% |
| Cost of Equity | 12.18% |
| Cost of Debt | 5.00% |
| WACC | 8.02% |